Caplight Directory>Companies>Science&Humans-preview>Scienceandhumans


Science&Humans

Science&Humans

Private
Toronto, OntarioHealthcare & Life Scienceshttps://scienceandhumans.com

Last Round

Series A

Jan 21, 2026

Total Funding Raised

$14.26M

Momentum Score

25 /100

Company Overview

Science&Humans is a Canadian healthtech company that operates a telemedicine platform offering personalized treatment for hormone health imbalances.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Patient Engagement, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

hormone healthtelehealth platformHormone Replacement TherapyHRTTestosterone Replacement TherapyTRTmenopause caremen's healthtelemedicinevirtual caresexual wellnessweight managementerectile dysfunction treatmentprescription deliveryat-home testingD2C healthcareemployee benefits platformONMEN

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Science&Humans Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Science&Humans Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 21, 2026
Series ADec 1, 2025
DebtDec 1, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Wendy Yu

CFO

Executive Team

Science&Humans Investors

Notable investors and investment history

InvestorRounds
CIBC Innovation BankingSeries A, Debt
WELL VenturesSeries A
Pender VenturesSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Michele Romanow named brand ambassador for 2026.

  • Nov 2, 2025

    Serves over 50,000 customers as Canada's largest hormone health platform.

View all signals

Science&Humans Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Science&Humans Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Science&Humans's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range77
Year Founded2018
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.